Seelos Therapeutics, Inc.Seelos Therapeutics, Inc.Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

SEEL fundamenta

Seelos Therapeutics, Inc. earnings per share and revenue

SEEL earnings per share for the last quarter are -0.80 USD whereas the estimation was -0.80 USD which accounts for 0.00% surprise. Estimated earnings per share for the next quarter are -1.48 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of SEEL earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning